A conducted study on MS patients (n = 20) showed that omega-3 PUFA supplementation may suppress the capacity of monocytes to synthesize IL-1 and TNF-α, and result in a decrease in the production of the inflammatory cytokines IL-1β, IL-2, TNF-α, and IFN-γ in people with MS [77]. Here, IFNG is linked to myeloid sarcoma.